Research on new and better ways to treat cancer. Covers radiotherapy, targeted microdroplets, nerve-injury protection, drug combinations, and tumor models.
Researchers at UNIGE identified a protein called S100A9 that regulates blood glucose and lipids, improving glucose management and reducing harmful side effects in diabetic mice. A clinical trial is underway to test the safety and efficacy of this new therapy in humans.
The RESILIENT trial found disease control in 114 out of 126 patients evaluable per protocol and progression-free survival. The study suggests that label-agnostic therapy regimens guided by Encyclopedic Tumor Analysis can offer meaningful clinical benefits for patients with relapsed refractory metastatic malignancies.
A new study published by The Menopause Society finds that fractional CO2 laser therapy is as effective and safe as vaginal estrogen in improving sexual and urinary functionality in postmenopausal women. After 6 months of follow-up, researchers reported similar improvements in symptoms such as vaginal dryness, itching, and burning.
Zachary Schug receives $2,679,000 NIH award to study link between high sugar/fat diet, alcohol use and cancer. He aims to uncover molecular mechanisms underlying this connection and develop novel therapies.
A new analysis of two international clinical trials predicts that benralizumab may be effective for a subpopulation of patients with moderate to very severe COPD who have elevated blood eosinophil counts and a history of frequent exacerbations. The study found no significant efficacy in reducing annual COPD exacerbation rates for patie...
A new study presents promising results from the CheckMate 358 trial, a phase I/II investigational immune-therapy trial combining nivolumab and ipilimumab for recurrent and metastatic cervical cancer. The combination showed higher clinical benefit rates compared to single-agent treatments.
The Blood and Immune Deficiency-Cellular Therapy Program (BID-CTP) integrates expertise from multiple medical specialties to treat rare blood and immune system diseases. Patients with hundreds of different primary immune deficiency diseases can now receive unified care through a single, multi-specialty team.
Researchers found PML dysfunction due to altered protein modification, specifically sumoylation, enables pancreatic tumor resistance to chemotherapeutic treatment. High PML expression and sumoylation are associated with better survival rates in patients.
Researchers created CAR T cells targeting BAFF-R, a surface marker found on B cells and cancerous B cells. This approach showed promise in killing cancer cells that lack CD19, reducing the risk of relapse in patients with lymphoma.
A single-session sleep education program has been shown to cure insomnia in many cancer survivors, according to a new study. Those who don't benefit from this approach are often helped by a more extensive three-session program. The findings suggest a 'stepped care' model can be effective for improving insomnia in cancer survivors.
Researchers propose targeting cancer patients' mindsets to improve their health, functioning, and well-being. They identify specific mindsets that can impact cancer patients' health, such as viewing cancer as manageable or seeing the body as capable and resilient.
Researchers at RMIT University have developed a non-viral gene delivery method that has proven effective in laboratory tests, opening the door to treatment of various genetic diseases. The method uses Metal Organic Frameworks (MOFs) and could significantly reduce the time and expense involved in bringing new treatments to market.
Scientists have made a breakthrough in understanding the construction of mitochondrial ribosomes, also known as mitoribosomes, which are crucial for protein synthesis. The study reveals that these structures undergo multiple assembly steps involving various proteins and machinery.
Researchers found that mitochondrial fission factor is a key regulator of cancer cell survival and proliferation. The protein's interaction with VDAC1 is critical for tumor cell growth, but disrupting this complex can activate mechanisms of mitochondrial cell death.
Markey researchers identify nuclear glycogen's role in cancer progression and find epigenetic connections between glycogen metabolism and gene expression. The study reveals new therapeutic targets to treat non-small cell lung cancers.
Cancer survival in the UK has improved since 1995, with significant increases in one-year and five-year survival rates for various cancers. Despite this progress, the UK still lags behind other high-income countries in cancer survival.
A Brazilian multicenter study found that older hospitalized patients with cancer have a high prevalence of malnutrition, affecting nearly half of the patient population. The study highlights the need for nutritional assessments soon after hospitalization to prevent malnutrition and weight loss.
The American Society for Gastrointestinal Endoscopy has released an updated guideline on screening and surveillance of Barrett's esophagus, aiming to improve patient outcomes. The guideline addresses various endoscopic procedures and technologies used in screening and surveillance, including advanced imaging and sampling modalities.
Scientists created a 3D map of a mouse genome using ultra-deep chromosome conformation capture technology, revealing surprising changes in genomic organization during development. The study used machine learning to gauge how easily accessible genes are for transcription, shedding light on gene regulation and its role in disease.
The European Society for Medical Oncology (ESMO) has announced the winners of its annual awards, recognizing Prof. Eric Van Cutsem's pioneering work in gastrointestinal oncology and Dr. Angelo Di Leo's lifetime achievements in cancer research and education. The ESMO Women for Oncology Award was also presented to Prof. Cristiana Sessa, ...
Scientists have discovered a key protein structure that could lead to the development of treatments for Epstein-Barr virus infections. The portal protein plays a crucial role in the virus's DNA entry and exit mechanisms, and understanding its structure may enable the design of virus-specific inhibitors.
The University of Texas at Arlington has been awarded over $2 million in Cancer Prevention & Research Institute of Texas (CPRIT) grants to support its thriving cancer research initiatives. Dr. Piya Ghose received a $2 million grant for her work on programmed cell death, while Dr. Yaowu Hao received $200,000 to investigate radioactive n...
Research funded by Cancer Research UK found that average monthly cigarette consumption fell by 24.4% based on survey data and 24.1% based on sales data between 2011 and 2018. The decline suggests that stricter tobacco laws and quitting smoking initiatives are working, with current smoking rates at 16% of English adults.
A national survey found that about one-third of middle- and high-school students were exposed to vaping aerosols in 2018, a 30% increase from previous years. The Centers for Disease Control and Prevention reported an alarming rise in second-hand e-cigarette exposure among young people.
The BC2 Basel Computational Biology Conference aims to bridge the gap between Big Data and clinical applications, featuring renowned experts from precision oncology to infectious diseases. Key takeaways include the importance of single-cell data in cancer research and biological big data analysis methods.
Researchers created a deformable nanolipogel-based delivery system for CRISPR knockout of oncogene Lcn2, reducing tumor growth by 77% in human and mouse models. The delivery method shows promise as a precise therapeutic tool for treating triple-negative breast cancer.
Women with breast cancer who experience depression, anxiety, or mental health conditions are more likely to use opioids and have lower survival rates. Researchers recommend alternative pain management options like physical therapy, massage, and acupuncture to improve treatment outcomes.
A clinical trial demonstrates the safety and feasibility of gold-silica nanoshells for treating localized prostate cancer, showing no serious side effects during treatment. The vast majority of treated lesions showed no evidence of tumor after 12 months.
Researchers analyzed the reaction mechanism of PUVA therapy using time-resolved laser spectroscopy. The process involves two stages: initial binding and cyclobutane ring formation, which triggers programmed cell death and destroys diseased cells.
A study published in Acta Neuropathologica Communications found that interregional differences in the somatic genetic landscape of glioblastoma affect prognosis. The research analyzed Japanese patients with IDH-wildtype GBM and discovered a biomarker, triple CNA, associated with survival duration.
A study by Massachusetts General Hospital researchers has found a mutation in the RABL3 gene linked to hereditary forms of pancreatic cancer. The discovery may lead to earlier diagnoses and improved treatments for patients with strong family histories.
Researchers from Bern, Switzerland have been awarded major grants by the US Department of Defense to study new treatments for prostate cancer and develop methods to preserve severed limbs. The projects aim to identify factors driving metastasis and improve survival rates in prostate cancer patients.
A two-step gene therapy treatment has shown promise in treating recurrent glioblastoma by boosting IL-12 production and enhancing antitumor immune cell infiltration. The treatment has also been found to be safe, with serious side effects easily reversible after discontinuing treatment.
Researchers found that DNA methylation patterns can affect the impact of aspirin on mortality in women with breast cancer. Women with certain DNA characteristics who take aspirin before a breast cancer diagnosis may live longer, according to the study published in Cancer journal.
A new AI system developed at UCLA has shown promising results in accurately reading biopsies and diagnosing breast cancer. The system outperformed human pathologists in distinguishing between ductal carcinoma in situ (DCIS) and atypia, a type of abnormal cell associated with higher breast cancer risk.
A study found that chaperone protein Hsp70 inhibits toxic protein aggregates in the androgen receptor, which causes Kennedy's disease and prostate cancer. Hsp70 may be useful as a therapeutic target to treat these conditions.
Adults aged 85 years and older account for the fastest-growing age group in the US, with higher cancer incidence rates but lower screening and treatment rates. The most common cancers among this population are lung, breast, prostate, and colorectum, but late-stage diagnosis and poorer survival outcomes are also reported.
A University of Technology Sydney study found that a micronized mineral compound reduced asbestos-induced cellular damage in cell lines and significantly slowed MM development in mouse models. The discovery offers new hope for treating MM and asbestosis, two incurable diseases.
Scientists at Oregon State University have discovered a protein modification that enables tumor cells to proliferate without harming healthy cells. This finding opens up new avenues for cancer therapies with minimal side effects.
Researchers have described a new treatment that could cope with Heterotopic Ossification and Fibrodysplasia Ossificans Progressiva using a PI3-kinase inhibitor. The study shows promising results in preclinical models, potentially leading to improved treatment options for patients.
A new study has found that elderly cancer patients who are HIV-positive have poorer outcomes compared to those without the virus. The research found higher mortality rates from breast and prostate cancers among HIV-infected patients.
Researchers compared outcomes in patients with and without HIV who received stage-appropriate cancer treatment after a cancer diagnosis at age 65. The study found no significant difference in overall survival between the two groups, suggesting that age alone may not be a determining factor in cancer treatment outcomes.
Scientists have discovered a crucial protective role of Polo-like kinase (PLK1) in guarding against severe DNA damage during cell division. PLK1 is essential for maintaining chromosome rigidity and preventing chromosome rearrangements that can lead to cancers.
A new DNA methylation test has been shown to accurately predict which cases of precancerous cervical disease will become more serious, helping women decide on treatment options. Most women with moderate dysplasia can be safely followed without surgery until their disease resolves.
A team of researchers at Ruhr-Universität Bochum has shown that the supposed disorder in the HMGA1a protein is not disorder after all. The protein adopts dynamic, more compact structures that depend on its phosphorylation state. This discovery could lead to new therapeutic strategies for cancers caused by HMGA1a.
Research from St. Jude Children's Research Hospital found a link between inherited BRCA2 mutations and an increased risk of childhood non-Hodgkin lymphoma. The study analyzed data from 1,380 lymphoma survivors and found that members with BRCA2 mutations were more likely to develop the disease.
Researchers found that antibiotics can reduce the number of cancer cells and diminish cancer in patients with CTCL, a rare type of lymphoma. The study suggests that aggressive antibiotic treatment may inhibit not only the bacteria but also the cancer cells.
Researchers at Kazan Federal University and Fox Chase Cancer Center have developed a safer alternative to existing drainage methods for malignant pleural effusion. The new hydrogel-based approach improved patient outcomes by stalling health deterioration and increasing survival rates by 55% compared to standard therapy.
A new benchmarking study has determined the best analysis tools for identifying errors in a patient's DNA that are responsible for driving disease. GRIDSS was found to be one of the most accurate options, detecting DNA rearrangements with high precision.
PCORI is funding two projects to expand use of PCORI-funded research findings in real-world practice. A $1.4 million project aims to increase lung cancer screening rates, while an $860,000 project seeks to improve care for adolescents with TBI through a self-guided online therapy program.
A global report found that one in three cancer patients struggle to access psychological support, with 34% saying it was not available despite needing it. The survey also identified key areas for improvement, including swift diagnosis, information-sharing, and integrated multidisciplinary care.
Researchers have discovered a potent KRAS inhibitor, BI-2852, that can target both active and inactive forms of the enzyme. The compound has shown promising results in lab assays, paving the way for the development of specific RAS inhibitors for cancer therapy.
A recent study published in CANCER found that the incidence of colorectal cancer in adults under 50 years old has increased in the United States since 1970. Younger adults are diagnosed with more advanced disease, and African American and Hispanic populations have a higher proportion of young onset disease.
A CUNY Graduate School of Public Health and Health Policy professor has received a $2.1 million NIH grant to investigate the connection between the human microbiome and cancer, with the goal of developing more effective treatments.
Researchers at St. Jude Children's Research Hospital have discovered an association between a mutation in the NEU1 gene and fibrotic conditions, including idiopathic pulmonary fibrosis. The study found that mice lacking the Neu1 gene developed muscle atrophy due to excessive connective tissue production.
St. Jude Children's Research Hospital scientists have determined the structure of the minichromosome maintenance complex, a ring-shaped enzyme that plays a central role in DNA replication. The research proposes a rotary mechanism to initiate DNA replication and may help solve one of biology's greatest mysteries.
A researcher at Oregon State University has received a $2.3 million grant to develop an effective treatment for cachexia, a muscle-wasting syndrome that kills up to 30% of cancer patients. The new research aims to preserve muscle mass and reduce death and suffering among patients with various cancers.
Dr. Carlo C. DiClemente, an internationally renowned scientist, will deliver the 11th Annual Jack Mendelson Honorary Lecture at the NIH. His presentation focuses on the necessity of relapse and recycling in recovery from alcohol use disorder using the Transtheoretical Model of behavior change.
A team at Brigham Young University studied how the mechanistic target of rapamycin (mTOR) complex is assembled, revealing its importance in regulating cell growth and survival. The researchers believe that understanding mTOR's assembly process could lead to new cancer therapies and treatments for diabetes.
A study led by Dr. Alliric Willis found that over 25% of low-risk thyroid cancer patients receive unnecessary radioactive iodine ablation treatment, carrying potential long-term risks and financial burdens. Younger patients, men, Hispanic, and Asian individuals are more at risk of overtreatment.